HiSiaddi is an innovative foreign trade service provider driven by dual engines of technology transformation and foreign trade services. We have established a "1+2+3+4=1" service system and can supply original factory goods of well-known brands for yucca saponin and oregano oil. As a research-and-development-oriented foreign trade service provider, HiSiaddi has repeatedly collaborated with factories on technology conversion and accurately grasped market demands, successfully resolving various customized product demands for yucca saponin and oregano oil. Below is a case of HiSiaddi addressing customized development requirements for yucca saponin and oregano oil products.
If you require more customized service solutions, please contact HiSiaddi customer service.
The client is VitaGreen of Canada, a top-tier premium natural health brand in North America. It specializes in organic dietary supplements, herbal immune preparations and gut health formulas, with products sold to high-end supermarkets, organic pharmacies and online membership systems across Canada, the United States and Australia. The brand strictly complies with Canada’s NPN Natural Health Product Certification, US FDA cGMP standards, EU Organic certification and NON-GMO non-GMO standards, adhering to the core positioning of "all-natural, high-activity, zero-additive and traceable". Its end products are priced at 30–80 Canadian dollars per bottle, representing high-premium goods with extremely stringent standards and fully customized requirements.
In March 2026, the client launched R&D for a new-generation "Dual-Effect Gut & Immune Complex Capsule", with core raw materials consisting of high-activity yucca saponin (≥60%) and high-carvacrol oregano oil (≥85%). The project required customized compound ratio formulation, organic certification, nano-emulsification technology, enteric coating, full English compliance documents, small-batch trial production and mass-scale formal manufacturing.
The client previously contacted 3 domestic extract factories, none of which could simultaneously meet the requirements of dual high-activity raw materials, precise compound ratio blending, complete organic certifications, customized nano-emulsification and high-grade pharmaceutical formulation standards. Common issues included limited capacity to supply only single raw materials, substandard active ingredient content, lack of organic certifications, failure to mitigate oregano oil’s irritation and poor solubility, and documents that failed to meet North American drug regulatory standards. The client’s R&D progress stalled and the new product launch timeline was delayed. It entrusted HiSiaddi with full responsibility for customized development, technical implementation, compliance processing and production delivery, requiring completion of lab trials → pilot trials → first mass production (50,000 bottles) within 45 days.
· Yucca Saponin: Raw yucca sourced organically from the Yucatán Peninsula, Mexico; saponin content ≥60%, polysaccharide ≥15%, fully water-soluble, no solvent residues, with EU Organic & US OMRI certifications.
· Oregano Oil: Distilled from organically cultivated oregano in Spain; carvacrol ≥85%, thymol ≥5%, zero pesticide residues, with EU Organic & US USDA Organic certifications.
· Compound Blending Ratio: Yucca saponin : oregano oil = 3:1 (weight ratio); nano-emulsification treatment with particle size ≤200 nm to resolve oregano oil’s irritation, oxidation instability and poor solubility.
· Formulation Specifications: Enteric soft capsules (to avoid active ingredient degradation by gastric acid); 500 mg complex raw material per capsule; cGMP-compliant production, NPN filing, full English Certificates of Analysis (COA), non-GMO declarations and traceability QR codes.
· Delivery Timeline: Complete lab trials (5 kg) → pilot trials (50 kg) → initial mass production (50,000 bottles) within 45 days.
· Long-Term Cooperation Plan: Annual procurement volume ≥50 tons of complex raw materials; subsequent expansion into pet health care and premium feed additive lines.
1. Scarce supply of dual high-activity certified raw materials: Very few suppliers offer yucca saponin and oregano oil simultaneously meeting organic certification, high active ingredient content, high activity and low residue standards; most conventional factories only supply domestic standard raw materials without North American/EU organic credentials.
2. Technical barriers in compound blending & nano-emulsification: Oregano oil is highly volatile, irritating and prone to oxidation. Direct mixing with aqueous yucca saponin causes phase separation and loss of active ingredients. Ordinary factories lack nano-emulsification equipment and technical capabilities to produce stable compound formulations.
3. Strict high-grade pharmaceutical production standards: Production requires cGMP workshops, enteric coating technology, rigorous microbial and endotoxin control, standards unattainable for most extract factories focused on feed/industrial-grade output without pharmaceutical formulation qualifications.
4. Complex compliance documentation system: Mandatory organic certificates, non-GMO declarations, traceability reports, NPN filing materials and full English COA testing reports aligned with FDA standards; conventional manufacturers cannot provide a complete set of English compliance documents.
5. Contradiction between small-batch trial runs and rapid mass production: The client required sequential lab and pilot trials to verify formulation stability prior to mass manufacturing, while ordinary factories impose high minimum order quantities, offer limited flexibility for trial production and feature lengthy lead times.
· Yucca Saponin: Coordinated domestically authorized processing plants partnered with Mexico’s AGRION. Raw material was sourced from organically grown yucca stems and leaves in the Yucatán Peninsula, processed via low-temperature water extraction and membrane separation purification. Final specifications: saponin 62%, polysaccharide 18%, fully water-soluble, zero ethanol residues, with EU Organic and OMRI certifications.
· Oregano Oil: Partnered with distilleries cooperating with organic oregano plantations in Spain. Fresh whole oregano herbs underwent low-temperature distillation, yielding oil with carvacrol 87%, thymol 6%, all 200 pesticide residue tests negative, certified EU Organic and USDA Organic.
· Pre-shipment Raw Material Testing: Full-panel testing of each batch (active components, pesticide residues, heavy metals, microorganisms, solvent residues) with English COA issued to meet FDA/NPN standards.
1. Ratio Optimization: Orthogonal experiments adjusted dosage of food-grade Tween 80 and soy lecithin emulsifiers per the client’s 3:1 blending ratio, establishing an optimal emulsification formula to eliminate phase separation, precipitation and active ingredient loss.
2. Nano-Emulsification Process: Adopted high-pressure homogenization nano-emulsifiers operating at 1000 bar to convert oregano oil into microspheres of 120–180 nm, uniformly dispersed in aqueous yucca saponin solution. The finished complex achieves ≥24 months stability, 90% improved water solubility, 70% reduced irritation and enhanced oxidation resistance.
3. Customized Enteric Coating: Hydroxypropyl Methylcellulose Phthalate (HPMCP) enteric coating material was selected with controlled coating thickness to ensure capsule stability in gastric fluid (stable at pH <5.5) and rapid active ingredient release in intestinal fluid (dissolves at pH ≥6.5), protecting active components from degradation.
4. Lab & Pilot Trial Validation
o Lab Trial (5 kg): Laboratory-scale testing verified ≥95% active ingredient retention rate, formulation stability, solubility and irritation reduction, meeting all target indicators.
o Pilot Trial (50 kg): cGMP workshop pilot production simulated full manufacturing workflows to validate batch consistency, production feasibility and microbial control; all indicators satisfied client requirements.
1. Factory Screening: Coordinated partner factories holding cGMP and dietary supplement production qualifications with extensive experience serving North American markets, deploying dedicated isolated production lines to prevent cross-contamination.
2. Production Control: Full aseptic operation, constant 25°C production temperature, nitrogen blanketing to prevent oregano oil oxidation, real-time online active ingredient testing and continuous microbial monitoring.
3. Custom Packaging: Food-grade brown light-shielding soft capsules for oxidation prevention; English labels compliant with FDA labeling regulations; tamper-evident aluminum foil sealing; neutral English outer carton packaging.
4. Initial Mass Production: 50,000 bottles of complex capsules with 500 mg active complex per capsule, consistent active ingredient content, qualified microbial levels, zero impurities and uniform appearance.
1. Organic Certification Documents: EU Organic & OMRI certificates for yucca saponin; EU Organic & USDA Organic certificates for oregano oil; organic production process statements.
2. Non-GMO & Traceability Materials: NON-GMO declarations, raw material traceability QR codes (traceable back to Mexican/Spanish plantations), full-process records covering planting, harvesting, extraction and manufacturing.
3. Drug Regulatory Filing & Testing: Canadian NPN filing materials, FDA cGMP compliance statements, full-panel English COA testing reports (active ingredients, pesticide residues, heavy metals, microorganisms, solvent residues) and endotoxin testing reports.
4. Packaging & Label Review: English labels fully compliant with FDA 21 CFR Part 101 regulations, including compliant ingredient listings, nutrition facts tables, functional claims and warning statements, passing pre-review by North American drug regulatory authorities.
1. 100% Fulfillment of All Customization Requirements
o Raw Materials: Dual organic certifications, high active ingredient content (yucca saponin 62%, oregano oil carvacrol 87%), low residual contaminants.
o Formulation: Stable 3:1 compound blending ratio, qualified nano-emulsification and enteric coating, ≥95% active ingredient retention rate.
o Production: cGMP workshop manufacturing, successful initial mass production of 50,000 bottles with consistent batch quality meeting all specifications.
o Compliance: Complete set of North American organic and regulatory documents, successfully completing NPN filing and FDA pre-review.
2. Precise On-Time Delivery Performance Lab trials (7 days) → pilot trials (15 days) → mass production (15 days) → document submission (8 days) fully completed within 45 days, delivered 3 days ahead of the client’s schedule, enabling the new product to officially enter premium organic pharmacy channels across Canada.
3. Deepened Long-Term Cooperation The client designated HiSiaddi as its exclusive China partner for complex raw material customization and manufacturing, signing a framework agreement for annual procurement of 50 tons of complex raw materials. Subsequent development of pet health care complex powders and premium feed additive lines was also entrusted to HiSiaddi, generating stable annual procurement volume worth 8 million Canadian dollars.
Client Testimonial: "HiSiaddi is a professional partner that truly understands North American premium dietary supplement standards, integrating raw material resources and technical capabilities. It has perfectly resolved four core challenges: sourcing dual high-activity organic raw materials, nano-emulsification, customized enteric coating and full compliance documentation. The efficient 45-day delivery and superior product quality far exceeded our expectations, making HiSiaddi a core pillar supporting our expansion into North America’s premium natural health market."
When foreign mid-to-high-end dietary supplement brands source customized yucca saponin + oregano oil complex products, their core pain points include limited availability of dual high-activity organic raw materials, high technical barriers for emulsification, stringent high-grade pharmaceutical production standards, complex North American compliance documentation and inflexible small-batch trial production. Ordinary factories can only supply single standard raw materials without nano-emulsification technology, pharmaceutical formulation qualifications, full English compliance documents or accessible trial production thresholds, making them unable to meet the extreme customization demands of mid-to-high-end clients.
HiSiaddi’s core competitive advantage lies in global raw material resource integration + core R&D technologies (nano-emulsification / enteric coating) + cGMP production implementation + full North American compliance processing + flexible trial and mass delivery. We precisely match high-grade pharmaceutical customization demands and connect the full industrial chain from raw material origins, formula R&D and technical implementation, through production control, compliance documentation and batch delivery. We efficiently resolve customization challenges for mid-to-high-end clients, guaranteeing product quality, regulatory compliance and delivery timelines, helping clients rapidly capture market share in North America’s premium natural health sector.
If you require more customized service solutions, please contact HiSiaddi customer service.
+86-13120989737 
info@hisiaddi.com 
English
